APA (7th ed.) Citation

BA, A., GC, F., A, L., CL, D., WJD, I., ME, Ø., . . . PP, S. (2021). Towards next generation antisense oligonucleotides: Mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides. Nucleic acids research, 49(16), 9026. https://doi.org/10.1093/nar/gkab718

Chicago Style (17th ed.) Citation

BA, Anderson, et al. "Towards Next Generation Antisense Oligonucleotides: Mesylphosphoramidate Modification Improves Therapeutic Index and Duration of Effect of Gapmer Antisense Oligonucleotides." Nucleic Acids Research 49, no. 16 (2021): 9026. https://doi.org/10.1093/nar/gkab718.

MLA (9th ed.) Citation

BA, Anderson, et al. "Towards Next Generation Antisense Oligonucleotides: Mesylphosphoramidate Modification Improves Therapeutic Index and Duration of Effect of Gapmer Antisense Oligonucleotides." Nucleic Acids Research, vol. 49, no. 16, 2021, p. 9026, https://doi.org/10.1093/nar/gkab718.